NEOS Boosts Stake in Centene; Analysts Weigh In on Stock Performance

NEOS Investment Management LLC increased its stake in Centene Co. by 31.2% in Q4, surpassing 31,000 shares worth nearly $1.9 million. Several institutional investors have also adjusted their holdings recently, indicating a strong interest in Centene. Analysts have mixed views on Centene's stock with varying price targets set by firms such as Wells Fargo, Cantor Fitzgerald, and Barclays. The company reported earnings that exceeded analyst expectations, demonstrating a health sector commitment to improving healthcare services for under-insured and uninsured families.